tiprankstipranks
Avidity Biosciences Inc (RNA)
NASDAQ:RNA
US Market

Avidity Biosciences (RNA) Cash flow

300 Followers

Avidity Biosciences Cash Flow

RNA's free cash flow for Q4 2023 was $15.64M. For the 2023 fiscal year, RNA's free cash flow was decreased by $15.80M and operating cash flow was $16.50M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -119.06M$ -119.06M$ -136.27M$ -94.81M$ -37.12M$ 2.49M
Investing Cash Flow
$ -130.07M$ -130.07M$ -189.96M$ -82.52M$ -7.79M$ -235.00K
Financing Cash Flow
$ 93.86M$ 93.86M$ 346.17M$ 176.32M$ 272.04M$ 89.23M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 544.46M$ 185.38M$ 340.66M$ 320.66M$ 321.71M$ 94.58M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
----$ 571.00K$ 322.00K
Issuance Of Capital Stock
$ 91.74M$ 91.74M$ 344.78M$ 174.68M$ 300.28M$ 72.62M
Issuance Of Debt
----$ 0.00$ 19.45M
Repayment Of Debt
----$ -4.68M$ -2.80M
Free Cash Flow
$ -123.29M$ -123.29M$ -139.09M$ -98.55M$ -38.21M$ 2.25M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Avidity Biosciences Cash Flow

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis